Related Articles
Role of Fyn expression in predicting the sensitivity to platinum‑based chemotherapy in patients with ovarian serous carcinoma
Six‑mRNA risk score system and nomogram constructed for patients with ovarian cancer
3‑Oxoacid CoA transferase 1 as a therapeutic target gene for cisplatin-resistant ovarian cancer
PRMT1 expression predicts sensitivity to platinum‑based chemotherapy in patients with ovarian serous carcinoma
Expression of UCP2 is associated with sensitivity to platinum‑based chemotherapy for ovarian serous carcinoma